InsiderSource

Zaks Tal Zvi

Director, Chief Medical Officer · SEC CIK 1690927
Insider at TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD ADAP Adaptimmune Therapeutics PLC MRNA Moderna, Inc.
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$28.73M
157 trades
Net flow
−$28.73M
Net selling
Total filings
199
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Apr 6, 2021 ΔOwn −24%

Zaks Tal Zvi sold $77.9K of MRNA, trimming their stake 24%.

−$77.9K
610 sh @ $128
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Apr 6, 2021 ΔOwn −41%

Zaks Tal Zvi sold $104.7K of MRNA, trimming their stake 41%.

−$104.7K
814 sh @ $129
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Apr 6, 2021 ΔOwn −49%

Zaks Tal Zvi sold $315.3K of MRNA, trimming their stake 49%.

−$315.3K
2,426 sh @ $130
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Apr 6, 2021 ΔOwn −100%

Zaks Tal Zvi sold $150.6K of MRNA, trimming their stake 100%.

−$150.6K
1,150 sh @ $131
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 23, 2021 ΔOwn NEW
+$25.1K
1,199 sh @ $21
Advertisement
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 23, 2021 ΔOwn −21%

Zaks Tal Zvi sold $36.4K of MRNA, trimming their stake 21%.

−$36.4K
255 sh @ $143
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 23, 2021 ΔOwn −39%

Zaks Tal Zvi sold $52.7K of MRNA, trimming their stake 39%.

−$52.7K
366 sh @ $144
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 23, 2021 ΔOwn −39%

Zaks Tal Zvi sold $33K of MRNA, trimming their stake 39%.

−$33K
227 sh @ $145
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 23, 2021 ΔOwn −83%

Zaks Tal Zvi sold $42.5K of MRNA, trimming their stake 83%.

−$42.5K
290 sh @ $146
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 23, 2021 ΔOwn −100%

Zaks Tal Zvi sold $9K of MRNA, trimming their stake 100%.

−$9K
61 sh @ $148
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 16, 2021 ΔOwn NEW
+$209.3K
10,000 sh @ $21
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 16, 2021 ΔOwn +0.3%
+$483
34 sh @ $14
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −4.1%

Zaks Tal Zvi sold $55.9K of MRNA, trimming their stake 4%.

−$55.9K
411 sh @ $136
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −8.3%

Zaks Tal Zvi sold $109.7K of MRNA, trimming their stake 8%.

−$109.7K
801 sh @ $137
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −6.8%

Zaks Tal Zvi sold $83.2K of MRNA, trimming their stake 7%.

−$83.2K
602 sh @ $138
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −3.6%

Zaks Tal Zvi sold $41.7K of MRNA, trimming their stake 4%.

−$41.7K
300 sh @ $139
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −24%

Zaks Tal Zvi sold $263.1K of MRNA, trimming their stake 24%.

−$263.1K
1,874 sh @ $140
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −49%

Zaks Tal Zvi sold $422.2K of MRNA, trimming their stake 49%.

−$422.2K
2,988 sh @ $141
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −69%

Zaks Tal Zvi sold $298.7K of MRNA, trimming their stake 69%.

−$298.7K
2,101 sh @ $142
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 16, 2021 ΔOwn −100%

Zaks Tal Zvi sold $136.9K of MRNA, trimming their stake 100%.

−$136.9K
957 sh @ $143
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 10, 2021 ΔOwn NEW
+$209.3K
10,000 sh @ $21
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 10, 2021 ΔOwn +15%
+$18K
1,478 sh @ $12
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Mar 10, 2021 ΔOwn +44%
+$71.1K
5,000 sh @ $14
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −9.4%

Zaks Tal Zvi sold $191K of MRNA, trimming their stake 9%.

−$191K
1,547 sh @ $123
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −1.8%

Zaks Tal Zvi sold $33.9K of MRNA, trimming their stake 2%.

−$33.9K
273 sh @ $124
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −9.3%

Zaks Tal Zvi sold $171.1K of MRNA, trimming their stake 9%.

−$171.1K
1,361 sh @ $126
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −10%

Zaks Tal Zvi sold $171.1K of MRNA, trimming their stake 10%.

−$171.1K
1,350 sh @ $127
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −16%

Zaks Tal Zvi sold $236.9K of MRNA, trimming their stake 16%.

−$236.9K
1,855 sh @ $128
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −27%

Zaks Tal Zvi sold $347K of MRNA, trimming their stake 27%.

−$347K
2,698 sh @ $129
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Mar 10, 2021 ΔOwn −31%

Zaks Tal Zvi sold $300.1K of MRNA, trimming their stake 31%.

−$300.1K
2,312 sh @ $130

Frequently asked questions

How is Zaks Tal Zvi's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Zaks Tal Zvi's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.